Trying to separate three different claims about methenolone enanthate: that it is the right molecule, that it is the right dose, and that it does something useful.
Baseline first. Without a baseline the after picture is decoration.
If you need three other compounds to notice the first one, you have not tested the first one.
My rule now: if a claim cannot survive being written down with the numbers attached, it is marketing.
Mechanism is not outcome, and a plausible pathway is the most expensive kind of evidence there is.
Haematocrit creep is the boring one that catches people at the six week mark.
Curious whether the popular dose has any basis or is just the convenient one.
What is the first thing you would read if you were starting from zero? Same for me with methenolone enanthate, unfortunately.
Three questions kill most of the confidence in a thread like this: sample size, blinding, who paid. Not on methenolone enanthate but the pattern is familiar.
If it needs three other compounds to notice, you have not tested the first one.
Log dose, time and sleep. Ten seconds a day and it turns the anecdote into something you can look at.
Log dose, time and sleep. Ten seconds a day and it turns the anecdote into something you can look at.
Same here.
Currently on methenolone enanthate myself.
How long before you can reasonably say something is or is not doing anything?